Back

Ischemic versus dilated cardiomyopathy - differences in clinical characteristics and prognosis depending on heart failure etiology.

29 August 2017 (15:35 - 16:25)
Organised by:
Congress Presentation Part of: Comorbidities in heart failure Prognosis ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Agata Tyminska

Medical University of Warsaw, Warsaw (Poland)

5 More presentations in this session

Presentation thumbnail
Atrial fibrillation or rapid ventricular response in patients with left ventricular dysfunction: which is relevant to the long-term clinical outcome?
Doctor G. Benfari (Verona, IT)
Abstract Slides
Presentation thumbnail
HYCHeF: a risk score to predict congestive heart failure incidence in hypertension. (based on 18795 individual patient data)
Doctor H. Le (Lyon, FR)
Abstract Slides
Presentation thumbnail
Intravenous iron therapy in acute decompensated heart failure patients with iron deficiency anaemia
Doctor A. Kamal (Cairo, EG)
Abstract Slides
Presentation thumbnail
Lectin-like oxidized LDL receptor-1 (LOX-1) in cardiomyocytes (CMs) is involved in the pathogenesis of doxorubicin (DOX)-induced cardiomyopathy
Doctor T. Aoyama (Minokamo, JP)
Abstract Slides
Presentation thumbnail
Elevated potassium levels in patients with congestive heart failure: incidence and clinical outcomes. A Danish population based cohort study
Doctor R. Thomsen (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
Comorbidities in heart failure

The Event

Event poster

ESC Congress 2017

29 August 2017 15:35 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources